Institutional & Family Asset Management, LLC Immuno Gen, Inc. Transaction History

Institutional & Family Asset Management, LLC

  • $846 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$4.26 - $7.48 $102 - $179
-24 Reduced 3.47%
667 $3,000
Q2 2020

Aug 14, 2020
SELL
$3.32 - $5.34 $102 - $165
-31 Reduced 4.29%
691 $3,000
Q4 2019

Feb 14, 2020
SELL
$2.25 - $5.8 $2 - $5
-1 Reduced 0.14%
722 $4,000
Q3 2019

Nov 14, 2019
BUY
$2.22 - $3.39 $37 - $57
17 Added 2.41%
723 $2,000
Q1 2018

May 14, 2018
BUY
$6.7 - $12.95 $4,730 - $9,142
706 New
706 $7,000

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email